Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice

Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. The availability of safe and effective tetravalent dengue vaccine is a global requirement to prevent epidemics, morbidity, and mortality associated with it. Methods: Five experimental groups (6 mice...

Full description

Bibliographic Details
Main Authors: Ajit Kulkarni, Rushil Bhat, Mansi Malik, Suvarna Sane, Sweta Kothari, Shashikant Vaidya, Abhay Chowdhary, Ranjana A. Deshmukh
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2017-03-01
Series:Iranian Journal of Medical Sciences
Subjects:
Dengue
Envelope domain III (EDIII)
Antibodies
Neutralizing
Vaccines
Online Access:http://ijms.sums.ac.ir/index.php/IJMS/article/view/2506

Internet

http://ijms.sums.ac.ir/index.php/IJMS/article/view/2506

Similar Items